The present disclosure relates to devices, systems, and methods for endoscopic suturing or stitching and, more particularly, to end effectors, systems and methods for endoscopic suturing and/or stitching through an access device such as a cannula.
Increasingly, more and more surgical procedures are being performed through small openings (e.g., an incision or a natural opening) in the skin with the goal of reducing the invasiveness of the procedures. As compared to the larger openings typically required in traditional procedures, smaller openings result in less trauma to the patient. By reducing the trauma to the patient, the time required for recovery is also reduced. Generally, the surgical procedures that are performed through small openings in the skin are referred to as “endoscopic.” If the procedure is performed on the patient's abdomen, the procedure is referred to as “laparoscopic.” Throughout the present disclosure, the term “minimally invasive” is to be understood as encompassing both endoscopic and laparoscopic procedures. Cannulas can be utilized during a minimally invasive procedure to facilitate passage of endoscopic instruments.
In many surgical procedures, including those involved in endoscopic surgery, it is often necessary to suture bodily organs or tissue. Endoscopic suturing procedures can be challenging due to the small openings through which the suturing of bodily organs or tissues must be accomplished. Typically, the dimensions of the needles of endoscopic stitching devices are restricted by spatial limitations of the cannulas utilized to introduce the stitching devices into the surgical site.
It would be advantageous to have an end effector of an endoscopic stitching device that can be advanced through spatially limited access devices (e.g., cannulas) while supporting long needles. The advancement of stitching devices with long needles into surgical sites would enable a clinician to suture tissue with larger thickness as compared to stitching devices with short needles.
Various embodiments of endoscopic stitching needles for use with an endoscopic stitching device are described, wherein the needle includes a first end portion that is movable relative to a second end portion. Being movable, the first end portion of the needle can be in a first, mis-aligned orientation relative to the second end portion of the needle. The first end portion of the needle can then be moved into a second, aligned orientation relative to the second end portion of the needle. The first end portion of the needle is adapted to engage a first jaw member of the endoscopic stitching device and the second end portion is adapted to engage a second jaw member of the endoscopic stitching device.
In embodiments of the needle, the first end portion pivots relative to the second end portion.
In some embodiments of the needle, a connecting portion is disposed between the first and second end portions. The connecting portion may be formed of a flexible material adapted to enable the first end portion to pivot relative to the second end portion.
In embodiments of the needle, the first end portion includes a locking feature and the second end portion includes a mating feature.
In certain embodiments of the needle, the connecting portion includes a first arm member that extends from the first end portion and a second arm member that extends from the second end portion. The first arm member may be secured to the second arm member by a pivot pin.
In embodiments of the needle, the first arm member includes the locking feature and the second arm member includes the mating feature. The locking feature and the mating feature are configured to selectively engage each other to at least temporarily lock the first and second end portions of the needle in an aligned configuration.
In certain embodiments of the needle, the first and second end portions are separate, and the first end portion of the needle is adapted to connect to the second end portion of the needle. The locking feature and the mating feature can be adapted to connect to form the first and second end portions into a unitary arrangement. The first and second end portions can be movable relative to each other between a first, misaligned position and a second, aligned position. In embodiments, the first and second end portions are adapted to connect in the second, aligned position.
In embodiments of the needle, the first end portion is adapted to receive the second end portion. The first end portion and the second end portion can support a compressible element adapted to enable the first and second end portions to move between a first, compressed position and a second, extended position. The compressible element can include at least one of a spring and a gas.
According to one aspect, an endoscopic stitching device includes an end effector and a needle.
The end effector of the endoscopic stitching device includes a first jaw member and a second jaw member. The first jaw member is movable relative to the second jaw member between an open state and a closed state. The end effector defines a height in the closed state that is measured between a bottom-most surface of the end effector and a top-most surface of the end effector.
In some embodiments, the needle defines a working length that is greater than the height of the end effector.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and, together with a general description of the disclosure given above, and the detailed description of the embodiment(s) given below, serve to explain the principles of the disclosure, wherein:
Minimally invasive suturing devices in accordance with the present disclosure enable the use of a needle that is longer than a width of a suturing device and/or an access device used to deliver the suturing device to the surgical site. Delivery of such a relatively long needle is achieved by moving a first portion of the needle relative to a second portion of the needle in a first direction to reduce a profile of the needle from a suturing state to an insertion state. In the insertion state of the needle, the needle can be retained by an end effector of the suturing device while the end effector is disposed in a first, insertion position. Once delivered to the surgical site, the needle can be reoriented to the suturing state, e.g., by moving the first portion of the needle in a second direction relative to the second portion of the needle where the second direction is opposite the first direction. When in the suturing state, minimally invasive suturing can be achieved by passing the needle back and forth between opposed jaw members of the end effector in a conventional manner.
For a more detailed description of suitable endoscopic surgical devices, systems, and methods for use with the various end effectors and needles described herein, reference can be made, for example, to U.S. Pat. No. 8,337,515 and to U.S. Patent Application Publication No. 2009/0312773, the entire contents of each of which are incorporated herein by reference. Details of various embodiments of minimally invasive suturing devices in accordance with the present disclosure will now be described in detail.
As used in the following detailed description, the term “clinician” refers to a doctor, nurse, or other health care provider and may include support personnel. The terms “proximal” or “trailing” each refer to a portion of a structure closer to a clinician, and the terms “distal” or “leading” each refer to a portion of a structure farther from the clinician.
Referring now in specific detail to the drawings, in which like reference numbers identify similar or identical elements,
First jaw member 110 defines a first needle receiving recess 112 and second jaw member 120 defines a second needle receiving recess 122. Each needle receiving recess 112, 122 is adapted to receive an end portion of a needle (e.g., needle 200) in releasable friction fit relation. As illustrated in
As described in U.S. Pat. No. 8,337,515 referenced above and as shown in
As seen in
In embodiments, actuation mechanism 150 can include any suitable mechanical and/or electrical component adapted to impart axial translation to guide member 140. For example, actuation mechanism 150 can include any number of springs, levers, gears, cables, electrical circuitry, and the like that are adapted to cooperate to translate guide member 140 between the proximal and distal positions.
The working length “WL” of the any of the presently described needles can be any suitable dimension. In some embodiments, the working length “WL” is greater than height “h” (see
With reference to
With continued reference to
As seen in
The needle 200 is positionable between a locked state (
With reference to
Needles 200 and 300 can be utilized with any suitable end effector such as end effectors 40 and 100 to enable the respective end effector to support one of the respective needles 200, 300 while maintaining a minimal profile suitable for insertion and/or removal through small openings such as, for example, through a 10 millimeter diameter cannula (not shown).
In use, with reference again to
With reference to
Alternatively, and or additionally, guide member 140 can be advanced distally and/or proximally, for example, upon an actuation of actuation mechanism 150, to engage second end portion 220 of needle 200 (e.g., with a distal end portion of guide member 140) and provide axial force to second end portion 220 to facilitate movement of second end portion 220 and orient needle 200 into the locked state. As can be appreciated, guide member 140 can be adapted to be translated distally and/or proximally as necessary to facilitate a positioning of needle 200 into the locked state. Additionally or alternatively, needle 200, in some embodiments, can be oriented from the unlocked state to the locked state while simultaneously secured to both jaw members 110, 120 (e.g., with first and second end portions at least partially secured within respective needle receiving recesses 112, 122 of jaw members 110, 122 by partially advanced grasping members 162, 164).
Upon positioning needle 200 in the locked state, end effector 100 can then be used to effectuate a suturing procedure similar to that described in U.S. Pat. No. 8,337,515 referenced above. For example, handle assembly 20 is actuated to pivot one or both of first and second jaw members 110, 120 between open and closed states for passing needle 200 between jaw members 110, 120 and drawing suture “S” through tissue. More particularly, with needle 200 secured to needle receiving recess 112 of first jaw member 110 (e.g., with grasping member 162), an actuation of a trigger 24 (
After completion of the first stitch, jaw members 110, 120 can then be opened again so that needle 200 can be transferred back from second jaw member 120 to the first jaw member 110 in like fashion upon another closing of jaw members 112, 114 to effectuate another stitch. This process, in whole, or in part, can be repeated as necessary until the tissue is sutured as desired.
Upon completion of the suturing procedure, guide member 140 can be positioned to receive second end portion 220 of needle 200 within opening 142 of guide member 140 to facilitate a pivoting movement of second end portion 220 of needle 200 relative to first end portion 210 of needle 200 when needle 200 is retained in needle receiving recess 112 (e.g., friction fit and/or grasping member 162). For example, when needle 200 is disposed in a locked state, second end portion 220 of needle 200 can be positioned within opening 142 of guide member 140, such as by translating guide member 140 and/or pivoting jaw members 110, 120 of end effector 100 as appropriate. Then, a subsequent sufficient proximal movement of guide member 140 can impart an axial and/or rotational force on second end portion 220 of needle 200 to unlock first and second end portions 210, 220 of needle 200. Upon unlocking needle 200, jaw members 110, 120 of end effector 100 and/or guide member 140 can be manipulated as appropriate to reposition first and second end portions 210, 220 within respective needle receiving recesses 112, 122 of respective first and second jaw members 110, 120 so that end effector 100 can be closed around needle 200 and back into the insertion position, for example, for removal from the surgical site.
Since the operation of needle 300 is similar to the use of needle 200 as detailed above, the operation of needle 300 is only described herein to the extent necessary to describe the differences in operation of needle 300. Needle 300 can be positioned in the bent or approximated configuration (
In temperature responsive embodiments of needle 300, for example, needle 300 is biased or urged from the bent configuration to the unbent configuration upon being subject to a predetermined temperature such as body temperature. Once inserted in the body, the temperature responsive properties of this embodiment of needle 300 maintain the needle 300 in the unbent configuration so that needle 300 can be used to effectuate a suturing procedure.
When finished suturing with the temperature responsive embodiment of needle 300, removal from the surgical site may be achieved by releasing needle 300 from both jaw members of one of the presently described end effectors and separating needle 300 from the end effector (e.g., with a separate grasping device) so that the end effector may be closed and withdrawn through the access device separate from needle 300.
As another example, in stress/pressure responsive embodiments of needle 300, needle 300 is biased or urged from the bent configuration to the unbent configuration upon being subject to a predetermined stress or pressure such as compressive closure force(s) imparted through an end effector that is greater than the closure force(s) required to effectuate a suturing procedure. More particularly, this embodiment of needle 300 has sufficient rigidity to effectuate a suturing procedure; however, this embodiment of needle 300 will bend upon an application of a predetermined amount of compressive closure force(s) that is greater than a rigidity threshold of the needle that is suitable for suturing. Thus, to remove from the surgical site when finished suturing, compressive closure forces can be applied to this embodiment of needle 300 that are greater than the closure forces required for suturing to thereby bend this embodiment of needle 300 back into the bent configuration to enable the end effector to achieve the minimal profile required during insertion. This minimal profile will enable a simultaneous removal of this embodiment 300 and the end effector. Alternatively, and/or additionally, this embodiment of needle 300 can be released from the end effector so that each is separately withdrawn as described above.
As seen in
In an insertion position, as seen in
In the laterally misaligned configuration, tip ends 510b, 520b of respective first and second end portions 510, 520 of needle 500 are secured within respective needle receiving recesses 412, 422 of end effector 400 and disposed in longitudinally aligned relation to one another, while connecting ends 510a, 520a (and respective mating recess and protuberance 512, 522) of respective first and second end portions 510, 520 of needle 500 are separated and disposed in laterally-adjacent relation with one another with each end portion 510, 520 imposing a lateral force on the other to maintain first and second end portions 510, 520 in the misaligned configuration. Further, in the misaligned configuration, connecting end 510a of first end portion 510 can be closer to second jaw member 420 than first jaw member 410 and connecting end 520a of second end portion 520 can be closer to first jaw member 410 than second jaw member 420. In addition, connecting ends 510a, 520a of respective first and second end portions 510, 520 can be spaced apart such that outer surfaces 510c, 520c of respective first and second end portions 510, 520 are disposed in contacting relation when first and second end portions 510, 520 are misaligned. Although first end portion 510 is shown left (when viewed from the front of device) of second end portion 520 in the insertion position, second end portion 520 can be positioned left of first end portion 510 in the insertion position.
With reference to
As seen in
Upon completion of the suturing procedure, needle 500 can be released from end effector 400 so that each is separately withdrawn as described above with respect to the temperature responsive embodiment of needle 300.
Rather than having end portion 510, 520 oriented in offset lateral relation, the end portions of the needle may be oriented in longitudinal offset relation as shown in the embodiment of
In use, similar to that described above with respect to needle 500, end effector 400 can be moved between an open or unapproximated position and a closed or approximated position to couple first and second end portions 610, 620 into a unitary arrangement that forms needle 600. Needle 600 can then be utilized to effectuate a suturing procedure as described above with respect to needle 500 and end effector 400. Upon completion of the suturing procedure, needle 600 and/or end effector 400 can be removed from the surgical site as described above with respect to needle 500 and end effector 400.
As can be appreciated, although the embodiments of first and second end portions of needles 500 and 600 are shown positioned in offset lateral (
As seen in
An approximation of first and second jaw members 710, 720 of end effector 700 compresses needle 800 from an extended position (
Any of the components of the presently described devices can be formed of any suitable metallic and/or polymeric material. Securement of any of the components of the presently described devices to any of the other components of the presently described devices can be effectuated using known fastening techniques such welding (e.g., ultrasonic), crimping, gluing, etc.
Persons skilled in the art will understand that the structures and methods specifically described herein and shown in the accompanying figures are non-limiting exemplary embodiments, and that the description, disclosure, and figures should be construed merely as exemplary of particular embodiments. It is to be understood, therefore, that the present disclosure is not limited to the precise embodiments described, and that various other changes and modifications may be effected by one skilled in the art without departing from the scope or spirit of the disclosure. For example, when finished using the present minimally invasive suturing devices, removal from the surgical site may be achieved while one of the presently described needles is secured to one of the presently described end effectors by sequentially pulling the access device and the end effector out of the incision in the patient's skin, with the access device being removed first (while remaining supported about the shaft of the suturing device) and the end effector being removed second. More particularly, with the access device removed, the end effector can be readily drawn through the incision since the patient's skin will have sufficient elasticity to enable removal of the end effector without reducing the height of the end effector. Subsequent to the removal of the end effector through the incision, the access device can be removed from the suturing device by advancing the access device off of the distal end of the end effector.
Additionally, the elements and features shown or described in connection with certain embodiments may be combined with the elements and features of certain other embodiments without departing from the scope of the present disclosure, and that such modifications and variations are also included within the scope of the present disclosure. Accordingly, the subject matter of the present disclosure is not limited by what has been particularly shown and described.
This application is a continuation of U.S. patent application Ser. No. 15/587,691, filed May 5, 2017, which is a continuation of U.S. patent application Ser. No. 14/465,865, filed Aug. 22, 2014, now U.S. Pat. No. 9,675,340, which claims the benefit of U.S. Provisional Patent Application No. 61/906,554, filed Nov. 20, 2013, the entire contents of each of which are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
1037864 | Carlson et al. | Sep 1912 | A |
1131163 | Saunders et al. | Mar 1915 | A |
1293565 | Smit | Feb 1919 | A |
1449087 | Bugbee | Mar 1923 | A |
1876792 | Thompson | Sep 1932 | A |
2213830 | Anastasi | Sep 1940 | A |
2880728 | Rights | Apr 1959 | A |
3090386 | Curtis | May 1963 | A |
3349772 | Rygg | Oct 1967 | A |
3470875 | Johnson | Oct 1969 | A |
3807407 | Schweizer | Apr 1974 | A |
3842840 | Schweizer | Oct 1974 | A |
3901244 | Schweizer | Aug 1975 | A |
3946740 | Bassett | Mar 1976 | A |
4021896 | Stierlein | May 1977 | A |
4109658 | Hughes | Aug 1978 | A |
4161951 | Scanlan, Jr. | Jul 1979 | A |
4164225 | Johnson et al. | Aug 1979 | A |
4236470 | Stenson | Dec 1980 | A |
4345601 | Fukuda | Aug 1982 | A |
4373530 | Kilejian | Feb 1983 | A |
4471781 | Di Giovanni et al. | Sep 1984 | A |
4491135 | Klein | Jan 1985 | A |
4580567 | Schweitzer et al. | Apr 1986 | A |
4621640 | Mulhollan et al. | Nov 1986 | A |
4635638 | Weintraub et al. | Jan 1987 | A |
4890615 | Caspari et al. | Jan 1990 | A |
4923461 | Caspari et al. | May 1990 | A |
4935027 | Yoon | Jun 1990 | A |
4957498 | Caspari et al. | Sep 1990 | A |
5059201 | Asnis | Oct 1991 | A |
5100421 | Christoudias | Mar 1992 | A |
5171257 | Ferzli | Dec 1992 | A |
5181919 | Bergman et al. | Jan 1993 | A |
5207693 | Phillips | May 1993 | A |
5217471 | Burkhart | Jun 1993 | A |
5242458 | Bendel et al. | Sep 1993 | A |
5254126 | Filipi et al. | Oct 1993 | A |
5261917 | Hasson et al. | Nov 1993 | A |
5281220 | Blake, III | Jan 1994 | A |
5336230 | Leichtling et al. | Aug 1994 | A |
5454823 | Richardson et al. | Oct 1995 | A |
5569301 | Granger et al. | Oct 1996 | A |
5591181 | Stone et al. | Jan 1997 | A |
5674229 | Tovey et al. | Oct 1997 | A |
5690652 | Wurster et al. | Nov 1997 | A |
5693071 | Gorecki | Dec 1997 | A |
5814054 | Kortenbach et al. | Sep 1998 | A |
5980538 | Fuchs et al. | Nov 1999 | A |
6056771 | Proto | May 2000 | A |
6126666 | Trapp et al. | Oct 2000 | A |
6224614 | Yoon | May 2001 | B1 |
6270508 | Klieman et al. | Aug 2001 | B1 |
8337515 | Viola et al. | Dec 2012 | B2 |
8454631 | Viola et al. | Jun 2013 | B2 |
8628545 | Cabrera et al. | Jan 2014 | B2 |
8876701 | Surti | Nov 2014 | B2 |
8968339 | Malkowski | Mar 2015 | B2 |
9072480 | Hart | Jul 2015 | B2 |
9271720 | Stone | Mar 2016 | B2 |
9675340 | Sniffin et al. | Jun 2017 | B2 |
9913639 | Woodard, Jr. | Mar 2018 | B2 |
10709442 | Sniffin | Jul 2020 | B2 |
20040176751 | Weitzner | Sep 2004 | A1 |
20040260314 | Lizardi | Dec 2004 | A1 |
20050149066 | Stafford | Jul 2005 | A1 |
20060020274 | Ewers | Jan 2006 | A1 |
20060224184 | Stefanchik | Oct 2006 | A1 |
20090221868 | Evans | Sep 2009 | A1 |
20090299406 | Swain | Dec 2009 | A1 |
20100057108 | Spivey | Mar 2010 | A1 |
20100228270 | Bogart et al. | Sep 2010 | A1 |
20110112555 | Overes | May 2011 | A1 |
20110257663 | Unsworth | Oct 2011 | A1 |
20120123471 | Woodard, Jr. | May 2012 | A1 |
20130023725 | Nose | Jan 2013 | A1 |
Number | Date | Country | |
---|---|---|---|
20200289111 A1 | Sep 2020 | US |
Number | Date | Country | |
---|---|---|---|
61906554 | Nov 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15587691 | May 2017 | US |
Child | 16887171 | US | |
Parent | 14465865 | Aug 2014 | US |
Child | 15587691 | US |